Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

STLN

$6.837.73%0.4902

Dopo l'orario di chiusura: 6.37-0.46 -6.74%

Starling Oncology, Inc. Common Stock (STLN)

Date: O: H: L: C: Vol:

Starling Oncology, Inc. Common Stock Borsa (STLN) Ultime notizie

Ultragenyx (RARE) Reports Q3 Loss, Lags Revenue Estimates - Zacks Investment Research

Congress Trade: Senator Richard Blumenthal Just Disclosed New Stock Trades - Quiver Quantitative

Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call - www.marketscreener.com

Starling Oncology (STLN) Stock Forum and Discussion - Moomoo

Starling Oncology, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (STLN) - Traders Union

Esquire Financial Holdings And 2 Other Growth Companies With Strong Insider Ownership - Simply Wall Street

Starling Oncology, Inc. (STLN) Stock Price History & Data - Traders Union

General counsel Katherine Hargis receives 1,000 and 87 stock units from Sterling Infrastructure (STRL). - Stock Titan

Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation - The Manila Times

UMH PROPERTIES, INC. DECLARES COMMON AND PREFERRED DIVIDENDS - The Manila Times

ARMOUR Residential REIT, Inc. Confirms October 2026 Common Share and Q4 2026 Series C Preferred Share Dividends - The Manila Times

Compass Diversified Declares Third Quarter 2026 Distributions on Series A, B and C Preferred Shares - The Manila Times

Antelope Enterprise Holdings Limited Announces $100 Million 'At-the-Market' Equity Offering Program - The Manila Times

Nutriband Marks Five Years on Nasdaq - CEO Letter to Shareholders - The Manila Times

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation - www.marketscreener.com

Cancer doctors will discuss clinical trial access and mental health care - Stock Titan

Starling Oncology, Inc.(NasdaqCM:STLN) added to S&P Health Care Services Select Industry Index - marketscreener.com

Income Statement - Intellectia AI

3 Growth Companies With High Insider Ownership Growing Earnings Up To 132% - simplywall.st

Starling Oncology at Wells Fargo conference: growth and profit take center stage - Investing.com

Vice Chairman Bradford Hively Sold A Bunch Of Shares In Starling Oncology - Simply Wall Street

Starling Oncology (STLN) director sells 298K shares under 10b5-1 plan - Stock Titan

Nearly $2M in Starling Oncology (STLN) stock planned for director sale - Stock Titan

Starling Oncology (TOI) holder pairs 12K-share buy with call option sale - Stock Titan

Starling Oncology launches platform for treatment authorization - Investing.com

Cancer-Care Platform Launches With More Services Planned - Stock Titan

Starling Oncology Company Profile & Introduction - Moomoo

The Oncology Institute, Inc. (STLN) stock price, news, quote and history - Yahoo Finance UK

Starling Oncology And 2 Other Growth Stocks Insiders Are Backing - simplywall.st

US$9.00 - That's What Analysts Think Starling Oncology, Inc. (NASDAQ:STLN) Is Worth After These Results - simplywall.st

Starling Oncology (STLN) Stock Rerates On Cash Gains As Margin Risks Linger - simplywall.st

Oncology Institute (STLN) Stock Price, News & Analysis $STLN - marketbeat.com

B. Riley Adjusts Price Target on Starling Oncology to $11 From $8, Maintains Buy Rating - Moomoo

Starling Oncology, Inc. - STLN - Stock Price Today - Zacks Investment Research

Starling Oncology, Inc. (STLN) stock price, news, quote and history - Yahoo Finance Singapore

The Oncology Institute, Inc. (STLN) Stock Price, News, Quote & History - Yahoo! Finance Canada

What date does Starling Oncology, Inc.'s (STLN) report Earnings - Earnings Calendar & Announcement - zacks.com

Earnings call transcript: Starling Oncology Q2 2026 revenue tops forecast, stock jumps - Investing.com

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance - GlobeNewswire

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance - Yahoo Finance

Diluted net income available to common stockholders of Starling Oncology, Inc. – NASDAQ:STLN - TradingView

Starling Oncology: STLN Stock Price Quote & News - Robinhood

The Oncology Institute Rebrands as Starling Oncology - Yahoo Finance

The Oncology Institute, Inc. will Change its Ticker to STLN from TOI - marketscreener.com

Oncology institute: 10% owner Jorey Chernett buys $87,750 stock - Investing.com

Lake Street initiates Oncology Institute stock coverage with buy rating - Investing.com

Form 4 Oncology Institute Inc For: 24 June By Investing.com - Investing.com Canada

The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 - GlobeNewswire

Oncology Institute earnings missed by $0.03, revenue topped estimates - Investing.com UK

Simile a STLN

GMRS$12.358.43%

SRTA$4.9812.05%